Effect of Aldosterone on Energy Starvation in Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Heart FailureNonischemic Dilated Cardiomyopathy
Interventions
DRUG

spironolactone

spironolactone 50 mg daily for 6 months

Trial Locations (1)

37232

Vanderbilt Heart and Vascular Institute, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00574119 - Effect of Aldosterone on Energy Starvation in Heart Failure | Biotech Hunter | Biotech Hunter